1 Caplan LR. Int racranial branch atheromatousdisease:a neglected, understudied, and underusedconcept[Z]. 1989, 39:1246-1250.2 庄君, 唐春花. Branch Atheromatous Disease研究进展[J]. 中风与神经疾病杂志, 2012, 29:565-566. 3 Yamamoto Y. Concept , pathophysiology andtreatment for branch atheromatous disease[J]. RinshoShinkeigaku, 2014, 54:289-297.4 Yamamoto Y, Ohara T, Hamanaka M, et al .Characteristics of intracranial branch atheromatousdisease and its association with progressive motordeficits[J]. J Neurol Sci, 2011, 304:78-82.5 Men X, Li J, Zhang B, et al. Homocysteine andC-reactive protein associated with progressionand prognosis of intracranial branch atheromatousdisease[J]. PLoS One, 2013, 8:e73030.6 Kwan MW, Mak W, Cheung RT, et al. Ischemicstroke related to intracranial branch atheromatousdisease and comparison with large and small arterydiseases[J]. J Neurol Sci, 2011, 303:80-84.7 Nakase T, Yoshioka S, Sasaki M, et al. ClinicalEvaluat ion of Lacunar Infarct ion and BranchAtheromatous Disease[J]. Journal of Stroke andCerebrovascular Diseases, 2013, 22:406-412.8 段振鹏, 代成波, 张玉虎, 等. 分支动脉粥样硬化病和小动脉闭塞的临床差异[J]. 中风与神经疾病杂志,2015:196-200.9 王双青. 分支动脉粥样硬化疾病的临床及高分辨磁共振研究[D]. 南方医科大学, 2014.10 Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality ofnonrandomized studies in meta-analyses[J]. Eur JEpidemiol, 2010, 25:603-605.11 Hozo SP, Djulbegovic B, Hozo I. Estimating the meanand variance from the median, range, and the size of asample[J]. BMC Med Res Methodol, 2005, 5:13.12 星野晴彦, 高木诚, 山本康正, 等. B r a n c hAtheromatous Disease の臨床経過と急性期の転帰 -- J-BAD Registry の結果から[J]. 脑卒中, 2011,33:37-44. |